Skip to content

Sodium bicarbonate ringer’s versus lactate ringer's in cardiac surgery patients with cardiopulmonary bypass: a retrospective observational study

Sodium bicarbonate ringer’s versus lactate ringer's in cardiac surgery patients with cardiopulmonary bypass: a retrospective observational study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041178
Enrollment
Unknown
Registered
2020-12-20
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elective surgery of heart valve, coronary artery bypass, large vessel, or surgery for children with complicated congenital heart disease

Interventions

bicarbonate ringer's:Sodium bicarbonate ringer's
lactate ringer's:lactate ringer's

Sponsors

The People's Hospital of Gaozhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 90 Years

Inclusion criteria

Inclusion criteria: 1. Elective surgery of heart valve , coronary artery bypass, large vessel, or surgery for children with complicated congenital heart disease; 2. Cardiopulmonary bypass duration over 90min.

Exclusion criteria

Exclusion criteria: 1. Possible brain damage; 2. Patients after cardiopulmonary resuscitation; 3. Patients with a history of hypermagnesemia or hypothyroidism; 4. Pregnant or breastfeeding; 5. Patients whose death is considered inevitable; 6. Other situations that researcher believes are not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
standard base excess (BE) at 24h;proportion of patients with creatinine concentration>25% at 24h after surgery;

Secondary

MeasureTime frame
serum lactate, HCO3-, BE, lactate clearance, ScvO2, CO2 gap from preoperative to 24h of surgery;change of serum electrolytes from preoperative to 24h of surgery;change of platelet, Hb count from preoperative to 24h of surgery;proportion and duration of renal replacement therapy (RRT) use;ICU mechanical ventilation utilization rate and duration;ICU vasoactive drugs use, amount and duration;total amount of blood products use from preoperative to 24h of surgery;total amount of crystaloid solution use from preoperative to 24h of surgery;ICU length of stay;Drug-related adverse events (AE) within 24 hours postoperative, including but not limited to the incidence of electrolyte disturbances during ICU;

Countries

China

Contacts

Public ContactMinghai Xian

The People's Hospital of Gaozhou

2366829481@qq.com+86 13927592283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026